Dublin, Ireland, 28 September 2022 – Orphan Drug Consulting celebrates its fifth anniversary.
Orphan Drug Consulting is proud to announce the celebration of 5 years in business. Since its foundation in 2017 by Evelyn Kelly, Orphan Drug Consulting has grown from a core team based in Ireland to a combined global group of 26 employees and consultants. Orphan Drug Consulting has a strong global presence with offices in Dublin, London, Boston, and Sydney partnering with over 35 pharmaceutical and biotech companies across the world to provide best-in-class support to the industry and a combined experience of launching products to over 100 companies in Europe, North America, LATAM and APAC.
This year Orphan Drug Consulting expanded its operations into the Asia Pacific market with the opening of an Australian office in Sydney and appointed Anne Capplis as Lead Consultant for the Asia Pacific region. Orphan Drug Consulting further expanded its existing market presence in the United States with the relocation of David Crowley, Head of Client Delivery, where he will oversee the ongoing expansion of Orphan Drug Consulting operations in Boston, MA.
Evelyn Kelly, Chief Executive Officer, and Founder of Orphan Drug Consulting commented: “I’m very proud to announce the celebration of Orphan Drug Consulting being 5 years in business. I credit our expert team for Orphan Drug Consulting’s continued success and expansion. We continue to be dedicated to providing market-leading expertise to both new and existing clients as we respond to the growing demand for our services. This year in particular has been a very exciting time in Orphan Drug Consulting’s expansion with the opening of our new Sydney office in Australia and our further growth into the US market. I’m incredibly fortunate to work with such a talented group of people, and I look forward to what the future brings for Orphan Drug Consulting.”
Jason Cameron, Chief Operating Officer of Orphan Drug Consulting added: “It’s a pleasure to be a part of the team at Orphan Drug Consulting as the company celebrates 5 years in business. I’ve witnessed Orphan Drug Consulting extend its offerings to better meet the needs of its clients and develop a skilled workforce of subject matter experts. Over the course of 5 years, Orphan Drug Consulting has hit many significant milestones globally and has deepened its presence in key markets in the industry such as the US and the APAC region. Orphan Drug Consulting has a bright future and I’m excited to continue working with our clients to provide product launch success.”
About Orphan Drug Consulting Ltd
Orphan Drug Consulting coordinates product launches into the US, EU, and other international markets providing strategic support in the areas of supply chain, quality assurance, vendor management, and entity management with its team of experienced industry professionals. From full-service solutions to solving specific immediate requirements, Orphan Drug Consulting is your partner of choice to manage market complexities ensuring your successful product launch to meet your patient’s needs.
For more information contact firstname.lastname@example.orgLeave a reply